28 related articles for article (PubMed ID: 21489836)
1. Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients.
Murakami T; Minami K; Harabayashi T; Maruyama S; Takada N; Kashiwagi A; Miyata H; Sato Y; Matsumoto R; Kikuchi H; Abe T; Ito YM; Murai S; Shinohara N; Harada H; Osawa T
Sci Rep; 2024 Mar; 14(1):6801. PubMed ID: 38514751
[TBL] [Abstract][Full Text] [Related]
2. Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.
Hurst CD; Cheng G; Platt FM; Castro MAA; Marzouka NS; Eriksson P; Black EVI; Alder O; Lawson ARJ; Lindskrog SV; Burns JE; Jain S; Roulson JA; Brown JC; Koster J; Robertson AG; Martincorena I; Dyrskjøt L; Höglund M; Knowles MA
Cell Rep Med; 2021 Dec; 2(12):100472. PubMed ID: 35028613
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma.
Biswas A; Sahoo S; Riedlinger GM; Ghodoussipour S; Jolly MK; De S
Commun Biol; 2023 Dec; 6(1):1292. PubMed ID: 38129585
[TBL] [Abstract][Full Text] [Related]
4. The role and function of PPARγ in bladder cancer.
Peng T; Wang G; Cheng S; Xiong Y; Cao R; Qian K; Ju L; Wang X; Xiao Y
J Cancer; 2020; 11(13):3965-3975. PubMed ID: 32328200
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum IL-8 and IL-10 in patients with ovarian cancer undergoing chemotherapy.
Zhang L; Liu W; Wang X; Wang X; Sun H
Oncol Lett; 2019 Feb; 17(2):2365-2369. PubMed ID: 30719112
[TBL] [Abstract][Full Text] [Related]
6. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
[TBL] [Abstract][Full Text] [Related]
7. Role of caveolin-2 in subcutaneous tumor growth and angiogenesis associated with syngeneic mouse Lewis lung carcinoma and B16 melanoma models.
Liu Y; Sowa G
Cancer Cell Microenviron; 2014; 1(6):. PubMed ID: 26005706
[TBL] [Abstract][Full Text] [Related]
8. Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis.
Liu Y; Jang S; Xie L; Sowa G
Cancer Res; 2014 Nov; 74(22):6452-62. PubMed ID: 25269481
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.
Valletti A; Gigante M; Palumbo O; Carella M; Divella C; Sbisà E; Tullo A; Picardi E; D'Erchia AM; Battaglia M; Gesualdo L; Pesole G; Ranieri E
PLoS One; 2013; 8(10):e78452. PubMed ID: 24194935
[TBL] [Abstract][Full Text] [Related]
11. Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
Dip N; Reis ST; Timoszczuk LS; Viana NI; Piantino CB; Morais DR; Moura CM; Abe DK; Silva IA; Srougi M; Dall'Oglio MF; Leite KR
J Urol; 2012 Nov; 188(5):1951-6. PubMed ID: 22999546
[TBL] [Abstract][Full Text] [Related]
12. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics and genomics progress in urothelial bladder cancer.
Netto GJ
Semin Diagn Pathol; 2013 Nov; 30(4):313-20. PubMed ID: 24342287
[TBL] [Abstract][Full Text] [Related]
14. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P
Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
[TBL] [Abstract][Full Text] [Related]
16. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
